跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ARTINIBSA 4% WITH EPINEPHRINE SOLUTION FOR INJECTION 1:100000 - HSA Drug Approval Details
Approvals
/
HSA
/
ARTINIBSA 4% WITH EPINEPHRINE SOLUTION FOR INJECTION 1:100000
Approved
THERAPEUTIC
ARTINIBSA 4% WITH EPINEPHRINE SOLUTION FOR INJECTION 1:100000
Laboratorios Inibsa, S.A.
🇸🇬 Health Sciences Authority
Approval Date
Mar 18, 2020
Approval ID
fa7021e921d1808c
Company
Laboratorios Inibsa, S.A.
Type
Therapeutic
Approval Details
Approval Id
fa7021e921d1808c
Drug Name
ARTINIBSA 4% WITH EPINEPHRINE SOLUTION FOR INJECTION 1:100000
Product Name
ARTINIBSA 4% WITH EPINEPHRINE SOLUTION FOR INJECTION 1:100000
Approval Number
SIN15913P
Approval Date
2020-03-18
Registrant
FONDACO PTE LTD
Licence Holder
FONDACO PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SOLUTION
Route Of Administration
SUBMUCOSAL
Atc Code
N01BB58
Atc Item Name
articaine, combinations
Pharma Manufacturer Name
FONDACO PTE LTD
Company Detail Path
/organization/fondaco-pte-ltd
Active Ingredients
Adrenaline Tartrate 0.018mg eqv Adrenaline
0.01mg
Articaine Hydrochloride
40.00 mg
ADRENALINE TARTRATE 0.018 MG EQV ADRENALINE
0.01 MG
ARTICAINE HYDROCHLORIDE
40 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 18, 2020
Approval ID
fa7021e921d1808c
Type
Therapeutic
Back to HSA Approvals
